e0642 Effect of intracoronary anisodamine on no-reflow phenomenon after PCI in mini-pig with AMI
نویسندگان
چکیده
منابع مشابه
Predictive Value and Impact of No-Reflow Phenomenon after Primary PCI
Background: Angiographic no-reflow after primary percutaneous coronary intervention (PCI) in patients with STelevation myocardial infarction (STEMI) may result in unfavorable outcome. Objectives: The aim of the work was to study the outcome of STEMI patients with no-reflow phenomenon. Patients and Methods: A total of 627 STEMI patients who underwent primary PCI within 24 hours of symptoms onset...
متن کاملNo-reflow phenomenon.
To the Editor: In reviewing no-reflow, Rezkalla and Kloner1 indicted injuryinduced microvascular changes, but did not mention spasm of resistance vessels, which might be the basic mechanism of no-reflow. I proposed in 1971 that no-reflow (“stasis”) is due to ischemic injury-induced spasm, and the evidence seemed convincing.2 Short coronary occlusions reversed no-reflow, and this was interpreted...
متن کامل'No-reflow' phenomenon.
A 57-year-old man presented with new anginal symptoms nine years after three-vessel coronary artery bypass grafting. Cardiac catherization revealed severely and diffusely diseased saphenous vein graft to the obtuse marginal coronary artery. Percutaneous coronary intervention was complicated by the ‘no-reflow’ phenomenon. The patient suffered a periprocedural myocardial infarction (peak troponin...
متن کاملNo-reflow phenomenon.
Because total coronary artery occlusion was found in the early hours of transmural myocardial infarction, most of our research interest and treatment strategies focus on epicardial coronary arteries.1 Little attention, however, is paid to the coronary microvasculature. When a coronary artery is occluded, detrimental changes occur in the cardiac capillaries and arterioles. After relief of the oc...
متن کاملClinical effect of preoperative high-dose atorvastatin against no-reflow after PCI
The aim of the present study was to evaluate the use of preoperative high-dose atorvastatin to prevent the no-reflow phenomenon after percutaneous coronary intervention (PCI). A total of 138 patients with ST-segment elevation myocardial infarction, admitted from March 2014 to January 2015, were enrolled and randomly divided into 3 groups of 46 individuals each. The groups included a control gro...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Heart
سال: 2010
ISSN: 1355-6037
DOI: 10.1136/hrt.2010.208967.642